Nicole Meslier Selected Research

Mandibular Advancement

1/2022	Long-term dentoskeletal side effects of mandibular advancement therapy in patients with obstructive sleep apnea: data from the Pays de la Loire sleep cohort.
1/2017	Impact of Mandibular Advancement Therapy on Endothelial Function in Severe Obstructive Sleep Apnea.
8/2009	Microvascular endothelial function in obstructive sleep apnea: Impact of continuous positive airway pressure and mandibular advancement.
1/2008	Mandibular advancement for obstructive sleep apnea: dose effect on apnea, long-term use and tolerance.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Nicole Meslier Research Topics

Disease

16	Obstructive Sleep Apnea 01/2022 - 01/2008
6	Apnea 01/2017 - 11/2002
5	Sleep Apnea Syndromes (Sleep Apnea) 05/2014 - 11/2002
4	Sleepiness 09/2021 - 07/2010
3	Neoplasms (Cancer) 01/2022 - 12/2020
3	Hypoxia (Hypoxemia) 01/2022 - 12/2020
3	Snoring 09/2021 - 01/2008
2	Obesity 12/2020 - 01/2014
2	Disorders of Excessive Somnolence (Hypersomnia) 01/2017 - 01/2014
2	Cardiovascular Diseases (Cardiovascular Disease) 01/2017 - 09/2012
2	Type 2 Diabetes Mellitus (MODY) 08/2015 - 05/2010
1	Stroke (Strokes) 01/2022
1	Myocardial Infarction 01/2022
1	Respiratory Tract Diseases (Respiratory Tract Disease) 01/2021
1	Necrosis 01/2019
1	Acute Coronary Syndrome 01/2019
1	Coronary Artery Disease (Coronary Atherosclerosis) 01/2019
1	Hypercapnia 01/2019
1	Cheyne-Stokes Respiration 01/2019
1	Inflammation (Inflammations) 01/2019
1	Central Sleep Apnea (Central Sleep Apnea Syndrome) 01/2019
1	Atherosclerosis 01/2018
1	Hyperemia 01/2018
1	Pain (Aches) 10/2017
1	Fatigue 01/2017
1	Non-alcoholic Fatty Liver Disease 11/2016
1	Fatty Liver 11/2016
1	Liver Cirrhosis (Hepatic Cirrhosis) 11/2016
1	Hypertension (High Blood Pressure) 08/2015
1	Superior Vena Cava Syndrome (Superior Vena Cava Obstruction) 06/2015
1	Metabolic Syndrome (Dysmetabolic Syndrome X) 06/2013
1	Dyslipidemias (Dyslipidemia) 06/2013
1	Obesity Hypoventilation Syndrome (Pickwickian Syndrome) 07/2010
1	Insulin Resistance 05/2010

Drug/Important Bio-Agent (IBA)

5	Oxygen (Dioxygen)IBA 09/2021 - 08/2009
3	Glucose (Dextrose)FDA LinkGeneric 01/2019 - 09/2012
2	salicylhydroxamic acid (SHAM)IBA 01/2019 - 01/2017
2	Biological ProductsIBA 01/2017 - 05/2010
2	Insulin (Novolin)FDA Link 08/2015 - 05/2010
2	Triglycerides (Triacylglycerol)IBA 06/2013 - 05/2010
1	polyurethane foamIBA 01/2022
1	omega-Chloroacetophenone (Mace)IBA 01/2022
1	Calcium Channel Blockers (Blockers, Calcium Channel)IBA 01/2021
1	N 30IBA 01/2021
1	Brain Natriuretic Peptide (Natrecor)FDA Link 01/2019
1	C-Reactive ProteinIBA 01/2019
1	P-SelectinIBA 01/2019
1	TicagrelorIBA 01/2019
1	Interleukin-6 (Interleukin 6)IBA 01/2019
1	Biomarkers (Surrogate Marker)IBA 01/2019
1	Aspirin (Acetylsalicylic Acid)FDA LinkGeneric 01/2019
1	Purinergic P2Y Receptor AntagonistsIBA 01/2019
1	Adiponectin ReceptorsIBA 01/2019
1	LeptinIBA 01/2019
1	PolyphenolsIBA 01/2018
1	Alanine Transaminase (SGPT)IBA 11/2016
1	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 08/2015
1	Blood Glucose (Blood Sugar)IBA 08/2015
1	Antidepressive Agents (Antidepressants)IBA 05/2014
1	Thyroid HormonesIBA 01/2014
1	HDL CholesterolIBA 06/2013
1	LipidsIBA 06/2013
1	Glycated Hemoglobin (Glycosylated Hemoglobin)IBA 09/2012
1	GasesIBA 07/2010
1	ORALIT (ORS)IBA 05/2010

Therapy/Procedure

9	Therapeutics 01/2022 - 01/2008
9	Continuous Positive Airway Pressure 01/2022 - 11/2002
4	Occlusal Splints 01/2022 - 01/2017
4	Mandibular Advancement 01/2022 - 01/2008
1	Catheters 06/2015
1	Positive-Pressure Respiration (Positive End-Expiratory Pressure) 07/2010
1	Pressure Transducers (Pressure Transducer) 11/2002